Global Oligonucleotide Therapeutics Drug Market Growth (Status and Outlook) 2026-2032

April 2026 | 97 pages | ID: G5B49EB9A72CEN
LP Information

Abstracts

The global Oligonucleotide Therapeutics Drug market size is predicted to grow from US$ 383 million in 2025 to US$ 579 million in 2032; it is expected to grow at a CAGR of 6.2% from 2026 to 2032.

Many pharmaceutical companies were conducting research on oligonucleotide therapy, which employs chemically synthesized nucleotide-like small molecule drugs with potential specificity similar to that of therapeutic antibodies.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the ?Oligonucleotide Therapeutics Drug Industry Forecast? looks at past sales and reviews total world Oligonucleotide Therapeutics Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected Oligonucleotide Therapeutics Drug sales for 2026 through 2032. With Oligonucleotide Therapeutics Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oligonucleotide Therapeutics Drug industry.

This Insight Report provides a comprehensive analysis of the global Oligonucleotide Therapeutics Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oligonucleotide Therapeutics Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Oligonucleotide Therapeutics Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oligonucleotide Therapeutics Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oligonucleotide Therapeutics Drug.

This report presents a comprehensive overview, market shares, and growth opportunities of Oligonucleotide Therapeutics Drug market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Antisense Oligonucleotide
• Aptamer
• Other

Segmentation by Application:

• Neuromuscular Diseases
• ATTR
• Hepatic VOD
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Biogen
• Sarepta Therapeutics
• Jazz Pharmaceuticals
• Bausch & Lomb
• Alnylam Pharmaceuticals
• Dynavax Technologies
• Kastle therapeutics
• Akcea Therapeutics

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Oligonucleotide Therapeutics Drug Market Size (2021-2032)
  2.1.2 Oligonucleotide Therapeutics Drug Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Oligonucleotide Therapeutics Drug by Country/Region (2021, 2025 & 2032)
2.2 Oligonucleotide Therapeutics Drug Segment by Type
  2.2.1 Antisense Oligonucleotide
  2.2.2 Aptamer
  2.2.3 Other
  2.2.4 Oligonucleotide Therapeutics Drug Market Size by Type
    2.2.4.1 Oligonucleotide Therapeutics Drug Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.4.2 Global Oligonucleotide Therapeutics Drug Market Size Market Share by Type (2021-2026)
2.3 Oligonucleotide Therapeutics Drug Segment by Application
  2.3.1 Neuromuscular Diseases
  2.3.2 ATTR
  2.3.3 Hepatic VOD
  2.3.4 Other
  2.3.5 Oligonucleotide Therapeutics Drug Market Size by Application
    2.3.5.1 Oligonucleotide Therapeutics Drug Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.5.2 Global Oligonucleotide Therapeutics Drug Market Size Market Share by Application (2021-2026)

3 OLIGONUCLEOTIDE THERAPEUTICS DRUG MARKET SIZE BY PLAYER

3.1 Oligonucleotide Therapeutics Drug Market Size Market Share by Player
  3.1.1 Global Oligonucleotide Therapeutics Drug Revenue by Player (2021-2026)
  3.1.2 Global Oligonucleotide Therapeutics Drug Revenue Market Share by Player (2021-2026)
3.2 Global Oligonucleotide Therapeutics Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 OLIGONUCLEOTIDE THERAPEUTICS DRUG BY REGION

4.1 Oligonucleotide Therapeutics Drug Market Size by Region (2021-2026)
4.2 Global Oligonucleotide Therapeutics Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas Oligonucleotide Therapeutics Drug Market Size Growth (2021-2026)
4.4 APAC Oligonucleotide Therapeutics Drug Market Size Growth (2021-2026)
4.5 Europe Oligonucleotide Therapeutics Drug Market Size Growth (2021-2026)
4.6 Middle East & Africa Oligonucleotide Therapeutics Drug Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Oligonucleotide Therapeutics Drug Market Size by Country (2021-2026)
5.2 Americas Oligonucleotide Therapeutics Drug Market Size by Type (2021-2026)
5.3 Americas Oligonucleotide Therapeutics Drug Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Oligonucleotide Therapeutics Drug Market Size by Region (2021-2026)
6.2 APAC Oligonucleotide Therapeutics Drug Market Size by Type (2021-2026)
6.3 APAC Oligonucleotide Therapeutics Drug Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Oligonucleotide Therapeutics Drug Market Size by Country (2021-2026)
7.2 Europe Oligonucleotide Therapeutics Drug Market Size by Type (2021-2026)
7.3 Europe Oligonucleotide Therapeutics Drug Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Oligonucleotide Therapeutics Drug by Region (2021-2026)
8.2 Middle East & Africa Oligonucleotide Therapeutics Drug Market Size by Type (2021-2026)
8.3 Middle East & Africa Oligonucleotide Therapeutics Drug Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL OLIGONUCLEOTIDE THERAPEUTICS DRUG MARKET FORECAST

10.1 Global Oligonucleotide Therapeutics Drug Forecast by Region (2027-2032)
  10.1.1 Global Oligonucleotide Therapeutics Drug Forecast by Region (2027-2032)
  10.1.2 Americas Oligonucleotide Therapeutics Drug Forecast
  10.1.3 APAC Oligonucleotide Therapeutics Drug Forecast
  10.1.4 Europe Oligonucleotide Therapeutics Drug Forecast
  10.1.5 Middle East & Africa Oligonucleotide Therapeutics Drug Forecast
10.2 Americas Oligonucleotide Therapeutics Drug Forecast by Country (2027-2032)
  10.2.1 United States Market Oligonucleotide Therapeutics Drug Forecast
  10.2.2 Canada Market Oligonucleotide Therapeutics Drug Forecast
  10.2.3 Mexico Market Oligonucleotide Therapeutics Drug Forecast
  10.2.4 Brazil Market Oligonucleotide Therapeutics Drug Forecast
10.3 APAC Oligonucleotide Therapeutics Drug Forecast by Region (2027-2032)
  10.3.1 China Oligonucleotide Therapeutics Drug Market Forecast
  10.3.2 Japan Market Oligonucleotide Therapeutics Drug Forecast
  10.3.3 Korea Market Oligonucleotide Therapeutics Drug Forecast
  10.3.4 Southeast Asia Market Oligonucleotide Therapeutics Drug Forecast
  10.3.5 India Market Oligonucleotide Therapeutics Drug Forecast
  10.3.6 Australia Market Oligonucleotide Therapeutics Drug Forecast
10.4 Europe Oligonucleotide Therapeutics Drug Forecast by Country (2027-2032)
  10.4.1 Germany Market Oligonucleotide Therapeutics Drug Forecast
  10.4.2 France Market Oligonucleotide Therapeutics Drug Forecast
  10.4.3 UK Market Oligonucleotide Therapeutics Drug Forecast
  10.4.4 Italy Market Oligonucleotide Therapeutics Drug Forecast
  10.4.5 Russia Market Oligonucleotide Therapeutics Drug Forecast
10.5 Middle East & Africa Oligonucleotide Therapeutics Drug Forecast by Region (2027-2032)
  10.5.1 Egypt Market Oligonucleotide Therapeutics Drug Forecast
  10.5.2 South Africa Market Oligonucleotide Therapeutics Drug Forecast
  10.5.3 Israel Market Oligonucleotide Therapeutics Drug Forecast
  10.5.4 Turkey Market Oligonucleotide Therapeutics Drug Forecast
10.6 Global Oligonucleotide Therapeutics Drug Forecast by Type (2027-2032)
10.7 Global Oligonucleotide Therapeutics Drug Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Oligonucleotide Therapeutics Drug Forecast

11 KEY PLAYERS ANALYSIS

11.1 Biogen
  11.1.1 Biogen Company Information
  11.1.2 Biogen Oligonucleotide Therapeutics Drug Product Offered
  11.1.3 Biogen Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Biogen Main Business Overview
  11.1.5 Biogen Latest Developments
11.2 Sarepta Therapeutics
  11.2.1 Sarepta Therapeutics Company Information
  11.2.2 Sarepta Therapeutics Oligonucleotide Therapeutics Drug Product Offered
  11.2.3 Sarepta Therapeutics Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Sarepta Therapeutics Main Business Overview
  11.2.5 Sarepta Therapeutics Latest Developments
11.3 Jazz Pharmaceuticals
  11.3.1 Jazz Pharmaceuticals Company Information
  11.3.2 Jazz Pharmaceuticals Oligonucleotide Therapeutics Drug Product Offered
  11.3.3 Jazz Pharmaceuticals Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Jazz Pharmaceuticals Main Business Overview
  11.3.5 Jazz Pharmaceuticals Latest Developments
11.4 Bausch & Lomb
  11.4.1 Bausch & Lomb Company Information
  11.4.2 Bausch & Lomb Oligonucleotide Therapeutics Drug Product Offered
  11.4.3 Bausch & Lomb Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Bausch & Lomb Main Business Overview
  11.4.5 Bausch & Lomb Latest Developments
11.5 Alnylam Pharmaceuticals
  11.5.1 Alnylam Pharmaceuticals Company Information
  11.5.2 Alnylam Pharmaceuticals Oligonucleotide Therapeutics Drug Product Offered
  11.5.3 Alnylam Pharmaceuticals Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Alnylam Pharmaceuticals Main Business Overview
  11.5.5 Alnylam Pharmaceuticals Latest Developments
11.6 Dynavax Technologies
  11.6.1 Dynavax Technologies Company Information
  11.6.2 Dynavax Technologies Oligonucleotide Therapeutics Drug Product Offered
  11.6.3 Dynavax Technologies Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 Dynavax Technologies Main Business Overview
  11.6.5 Dynavax Technologies Latest Developments
11.7 Kastle therapeutics
  11.7.1 Kastle therapeutics Company Information
  11.7.2 Kastle therapeutics Oligonucleotide Therapeutics Drug Product Offered
  11.7.3 Kastle therapeutics Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 Kastle therapeutics Main Business Overview
  11.7.5 Kastle therapeutics Latest Developments
11.8 Akcea Therapeutics
  11.8.1 Akcea Therapeutics Company Information
  11.8.2 Akcea Therapeutics Oligonucleotide Therapeutics Drug Product Offered
  11.8.3 Akcea Therapeutics Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 Akcea Therapeutics Main Business Overview
  11.8.5 Akcea Therapeutics Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Oligonucleotide Therapeutics Drug Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Oligonucleotide Therapeutics Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Antisense Oligonucleotide
Table 4. Major Players of Aptamer
Table 5. Major Players of Other
Table 6. Oligonucleotide Therapeutics Drug Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Oligonucleotide Therapeutics Drug Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Oligonucleotide Therapeutics Drug Market Size Market Share by Type (2021-2026)
Table 9. Oligonucleotide Therapeutics Drug Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Oligonucleotide Therapeutics Drug Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Oligonucleotide Therapeutics Drug Market Size Market Share by Application (2021-2026)
Table 12. Global Oligonucleotide Therapeutics Drug Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Oligonucleotide Therapeutics Drug Revenue Market Share by Player (2021-2026)
Table 14. Oligonucleotide Therapeutics Drug Key Players Head office and Products Offered
Table 15. Oligonucleotide Therapeutics Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Oligonucleotide Therapeutics Drug Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Oligonucleotide Therapeutics Drug Market Size Market Share by Region (2021-2026)
Table 20. Global Oligonucleotide Therapeutics Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Oligonucleotide Therapeutics Drug Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Oligonucleotide Therapeutics Drug Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Oligonucleotide Therapeutics Drug Market Size Market Share by Country (2021-2026)
Table 24. Americas Oligonucleotide Therapeutics Drug Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Oligonucleotide Therapeutics Drug Market Size Market Share by Type (2021-2026)
Table 26. Americas Oligonucleotide Therapeutics Drug Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Oligonucleotide Therapeutics Drug Market Size Market Share by Application (2021-2026)
Table 28. APAC Oligonucleotide Therapeutics Drug Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Oligonucleotide Therapeutics Drug Market Size Market Share by Region (2021-2026)
Table 30. APAC Oligonucleotide Therapeutics Drug Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Oligonucleotide Therapeutics Drug Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Oligonucleotide Therapeutics Drug Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Oligonucleotide Therapeutics Drug Market Size Market Share by Country (2021-2026)
Table 34. Europe Oligonucleotide Therapeutics Drug Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Oligonucleotide Therapeutics Drug Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Oligonucleotide Therapeutics Drug Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Oligonucleotide Therapeutics Drug Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Oligonucleotide Therapeutics Drug Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Oligonucleotide Therapeutics Drug
Table 40. Key Market Challenges & Risks of Oligonucleotide Therapeutics Drug
Table 41. Key Industry Trends of Oligonucleotide Therapeutics Drug
Table 42. Global Oligonucleotide Therapeutics Drug Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Oligonucleotide Therapeutics Drug Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Oligonucleotide Therapeutics Drug Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Oligonucleotide Therapeutics Drug Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Biogen Details, Company Type, Oligonucleotide Therapeutics Drug Area Served and Its Competitors
Table 47. Biogen Oligonucleotide Therapeutics Drug Product Offered
Table 48. Biogen Oligonucleotide Therapeutics Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Biogen Main Business
Table 50. Biogen Latest Developments
Table 51. Sarepta Therapeutics Details, Company Type, Oligonucleotide Therapeutics Drug Area Served and Its Competitors
Table 52. Sarepta Therapeutics Oligonucleotide Therapeutics Drug Product Offered
Table 53. Sarepta Therapeutics Oligonucleotide Therapeutics Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Sarepta Therapeutics Main Business
Table 55. Sarepta Therapeutics Latest Developments
Table 56. Jazz Pharmaceuticals Details, Company Type, Oligonucleotide Therapeutics Drug Area Served and Its Competitors
Table 57. Jazz Pharmaceuticals Oligonucleotide Therapeutics Drug Product Offered
Table 58. Jazz Pharmaceuticals Oligonucleotide Therapeutics Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Jazz Pharmaceuticals Main Business
Table 60. Jazz Pharmaceuticals Latest Developments
Table 61. Bausch & Lomb Details, Company Type, Oligonucleotide Therapeutics Drug Area Served and Its Competitors
Table 62. Bausch & Lomb Oligonucleotide Therapeutics Drug Product Offered
Table 63. Bausch & Lomb Oligonucleotide Therapeutics Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Bausch & Lomb Main Business
Table 65. Bausch & Lomb Latest Developments
Table 66. Alnylam Pharmaceuticals Details, Company Type, Oligonucleotide Therapeutics Drug Area Served and Its Competitors
Table 67. Alnylam Pharmaceuticals Oligonucleotide Therapeutics Drug Product Offered
Table 68. Alnylam Pharmaceuticals Oligonucleotide Therapeutics Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Alnylam Pharmaceuticals Main Business
Table 70. Alnylam Pharmaceuticals Latest Developments
Table 71. Dynavax Technologies Details, Company Type, Oligonucleotide Therapeutics Drug Area Served and Its Competitors
Table 72. Dynavax Technologies Oligonucleotide Therapeutics Drug Product Offered
Table 73. Dynavax Technologies Oligonucleotide Therapeutics Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Dynavax Technologies Main Business
Table 75. Dynavax Technologies Latest Developments
Table 76. Kastle therapeutics Details, Company Type, Oligonucleotide Therapeutics Drug Area Served and Its Competitors
Table 77. Kastle therapeutics Oligonucleotide Therapeutics Drug Product Offered
Table 78. Kastle therapeutics Oligonucleotide Therapeutics Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Kastle therapeutics Main Business
Table 80. Kastle therapeutics Latest Developments
Table 81. Akcea Therapeutics Details, Company Type, Oligonucleotide Therapeutics Drug Area Served and Its Competitors
Table 82. Akcea Therapeutics Oligonucleotide Therapeutics Drug Product Offered
Table 83. Akcea Therapeutics Oligonucleotide Therapeutics Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Akcea Therapeutics Main Business
Table 85. Akcea Therapeutics Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Oligonucleotide Therapeutics Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oligonucleotide Therapeutics Drug Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Oligonucleotide Therapeutics Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Oligonucleotide Therapeutics Drug Sales Market Share by Country/Region (2025)
Figure 8. Oligonucleotide Therapeutics Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Oligonucleotide Therapeutics Drug Market Size Market Share by Type in 2025
Figure 10. Oligonucleotide Therapeutics Drug in Neuromuscular Diseases
Figure 11. Global Oligonucleotide Therapeutics Drug Market: Neuromuscular Diseases (2021-2026) & ($ millions)
Figure 12. Oligonucleotide Therapeutics Drug in ATTR
Figure 13. Global Oligonucleotide Therapeutics Drug Market: ATTR (2021-2026) & ($ millions)
Figure 14. Oligonucleotide Therapeutics Drug in Hepatic VOD
Figure 15. Global Oligonucleotide Therapeutics Drug Market: Hepatic VOD (2021-2026) & ($ millions)
Figure 16. Oligonucleotide Therapeutics Drug in Other
Figure 17. Global Oligonucleotide Therapeutics Drug Market: Other (2021-2026) & ($ millions)
Figure 18. Global Oligonucleotide Therapeutics Drug Market Size Market Share by Application in 2025
Figure 19. Global Oligonucleotide Therapeutics Drug Revenue Market Share by Player in 2025
Figure 20. Global Oligonucleotide Therapeutics Drug Market Size Market Share by Region (2021-2026)
Figure 21. Americas Oligonucleotide Therapeutics Drug Market Size 2021-2026 ($ millions)
Figure 22. APAC Oligonucleotide Therapeutics Drug Market Size 2021-2026 ($ millions)
Figure 23. Europe Oligonucleotide Therapeutics Drug Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Oligonucleotide Therapeutics Drug Market Size 2021-2026 ($ millions)
Figure 25. Americas Oligonucleotide Therapeutics Drug Value Market Share by Country in 2025
Figure 26. United States Oligonucleotide Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Oligonucleotide Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Oligonucleotide Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Oligonucleotide Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Oligonucleotide Therapeutics Drug Market Size Market Share by Region in 2025
Figure 31. APAC Oligonucleotide Therapeutics Drug Market Size Market Share by Type (2021-2026)
Figure 32. APAC Oligonucleotide Therapeutics Drug Market Size Market Share by Application (2021-2026)
Figure 33. China Oligonucleotide Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Oligonucleotide Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Oligonucleotide Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Oligonucleotide Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 37. India Oligonucleotide Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Oligonucleotide Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Oligonucleotide Therapeutics Drug Market Size Market Share by Country in 2025
Figure 40. Europe Oligonucleotide Therapeutics Drug Market Size Market Share by Type (2021-2026)
Figure 41. Europe Oligonucleotide Therapeutics Drug Market Size Market Share by Application (2021-2026)
Figure 42. Germany Oligonucleotide Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 43. France Oligonucleotide Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Oligonucleotide Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Oligonucleotide Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Oligonucleotide Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Oligonucleotide Therapeutics Drug Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Oligonucleotide Therapeutics Drug Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Oligonucleotide Therapeutics Drug Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Oligonucleotide Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Oligonucleotide Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Oligonucleotide Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Oligonucleotide Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Oligonucleotide Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Oligonucleotide Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 56. APAC Oligonucleotide Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 57. Europe Oligonucleotide Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Oligonucleotide Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 59. United States Oligonucleotide Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 60. Canada Oligonucleotide Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 61. Mexico Oligonucleotide Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 62. Brazil Oligonucleotide Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 63. China Oligonucleotide Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 64. Japan Oligonucleotide Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 65. Korea Oligonucleotide Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Oligonucleotide Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 67. India Oligonucleotide Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 68. Australia Oligonucleotide Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 69. Germany Oligonucleotide Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 70. France Oligonucleotide Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 71. UK Oligonucleotide Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 72. Italy Oligonucleotide Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 73. Russia Oligonucleotide Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 74. Egypt Oligonucleotide Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 75. South Africa Oligonucleotide Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 76. Israel Oligonucleotide Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 77. Turkey Oligonucleotide Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 78. Global Oligonucleotide Therapeutics Drug Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Oligonucleotide Therapeutics Drug Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Oligonucleotide Therapeutics Drug Market Size 2027-2032 ($ millions)